6 Amendments of Angelo CIOCCA related to 2017/0328(COD)
Amendment 10 #
Draft legislative resolution
Paragraph 2
Paragraph 2
2. RegDeplorets that the European Parliament - and ultimately the representatives of the Union’s citizens - were not fully involved ine fact that the conclusion of the procedure to select the new seat of the European Medicines Agency (EMA), which was eventually concluded by was left to chance through the drawing of lots, despite it being such an important decision; decisions in relation to the location of bodies and agencies need, and legally should, be taken under the ordinary legislative procedure, fully respecting the European Parliament's prerogatives, whereby the European Parliament and the Council are equal co- legislators;
Amendment 20 #
Draft legislative resolution
Paragraph 3
Paragraph 3
3. Calls on the budgetary authorities and the Commission to ensure that the costs relating to the change in the seat of EMA will be fully covered by the current host countrygeneral budget of the Union;
Amendment 26 #
Draft legislative resolution
Paragraph 4
Paragraph 4
4. Calls on the budgetary authorities and the Commission to ensure that theany unexpected additional costs relating to the double transfer of the seat of EMA, first to a temporary location, and then to the Vivaldi Building, will be fully covered by the Dutch government and thus will not adversely affect the general budget of the Union;
Amendment 33 #
Draft legislative resolution
Paragraph 5
Paragraph 5
5. Calls on the budgetary authorities and the Commission to ensure that the double transfer will not jeopardise the normal operational needs of EMA, and will guarantee business continuity and EMA’s smooth functioning, without disruption, beyond March 2019;
Amendment 39 #
Proposal for a regulation
Recital 1
Recital 1
(1) In the context of the United Kingdom's notification on 29 March 2017 of its intention to leave the Union, pursuant to Article 50 of the Treaty on European Union, the other 27 Member States, meeting on 20 November 2017 in the margins of the General Affairs Council (‘Article 50’), selected Amsterdam, the Netherlands, as the new seat of the European Medicines Agency. However, the Executive Director was subsequently forced to acknowledge1a that the Amsterdam headquarters would not enable the Agency to become fully operational on schedule. The new seat should therefore be located in Milan (Italy), which was initially unsuccessful purely as a result of a random draw but fully satisfies all the logistic requirements
Amendment 48 #
Proposal for a regulation
Article 1 – paragraph 1
Article 1 – paragraph 1
Regulation (EC) No 726/2004
Article 71a
Article 71a
The Agency shall have its seat in Amsterdam, the NetherlandsMilan, Italy.